Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 Dittmar et al.
Published: 16 March 2021| Version 2 | DOI: 10.17632/4m9sygn632.2
Contributor:
Sara Cherry
Description
Supplementary Data sets
Files
Institutions
University of Pennsylvania
Categories
High-Throughput Screening, Drug Screening